The global bioresorbable polymers market was valued at USD 1.30 billion in 2022 and is projected to experience robust growth, with an expected compound annual growth rate (CAGR) of 13.8% from 2023 to 2030. This growth is primarily driven by several key factors, including a rising global awareness of health and wellness, improvements in healthcare infrastructure, and an increasing number of surgical procedures performed worldwide. According to data from the National Library of Medicine (NLM) in 2020, approximately 310 million major surgeries are conducted globally each year. Out of these, around 20 million surgeries are performed in Europe, while 40 to 50 million surgeries are conducted annually in the U.S. The increasing frequency of surgeries, coupled with a growing demand for advanced medical technologies, is expected to significantly boost the adoption of bioresorbable polymers in healthcare.

Bioresorbable polymers, also known as bioabsorbable polymers, belong to a class of materials that can be gradually broken down and absorbed by the human body over time, making them particularly valuable in medical applications. These polymers are widely used in various fields, with the medical sector being the most prominent. In medical applications, bioresorbable polymers are commonly found in a wide range of devices and implants, including sutures, screws, tissue scaffolds, plates, and stents. The key advantage of using these materials in such applications is that they naturally dissolve in the body, eliminating the need for a second surgery to remove them after the device has fulfilled its purpose.

In addition to their use in medical devices, bioresorbable polymers are also employed in drug delivery systems, such as nanoparticles or microspheres. These drug delivery systems are designed to release medications in a controlled manner over a specific period of time, after which the polymers dissolve safely in the body, removing the need for removal procedures. This controlled release mechanism can enhance the effectiveness of treatments and reduce the risks of side effects, contributing to better patient outcomes.

Gather more insights about the market drivers, restrains and growth of the Bioresorbable Polymers Market

Regional Insights

North America

North America was the dominant region in the global bioresorbable polymers market in 2022, accounting for the largest revenue share of 32.5%. This leading position is primarily due to the increasing demand for bioresorbable polymers in drug delivery and orthopedic applications across the region. The U.S. plays a critical role in driving market growth, serving as a major hub for research and development (R&D) in the healthcare industry. The nation’s strong R&D infrastructure in biotechnology and medical devices further supports the adoption and innovation of bioresorbable polymers. Additionally, the rising demand for orthopedic procedures and drug delivery systems contributes to the sustained growth in polymer consumption in these sectors.

For instance, data from the American Joint Replacement Registry (AJRR) in 2022 reported that more than 2.8 million knee and hip procedures were conducted across 1,250 healthcare institutions in the U.S. This represented a remarkable 14% increase in the total number of procedures compared to the previous year, underscoring the growing demand for medical procedures that benefit from bioresorbable polymers. The U.S. now hosts the world’s largest arthroplasty registry, which highlights the country’s leadership in orthopedic surgeries.

Moreover, the rising healthcare expenditure in the U.S. further fuels the market. According to the American Medical Association, U.S. healthcare spending increased by 2.7% in 2021, reaching USD 4.3 trillion, or USD 12,914 per capita. This substantial investment in healthcare infrastructure and services creates a favorable environment for the growth of bioresorbable polymers, especially in areas like orthopedic implants and drug delivery systems.

Asia Pacific (APAC)

Asia Pacific (APAC) is expected to experience the fastest growth in the bioresorbable polymers market, with a projected CAGR of 15.9% from 2023 to 2030. This rapid growth is driven by several key factors, including the growing geriatric population in countries such as China and Japan, which is increasing the demand for medical procedures. The rise in elderly populations, who often require surgeries, is expected to directly contribute to the need for bioresorbable materials in medical devices and treatments.

In addition to the aging demographic, economic growth in emerging countries within the region, such as India and China, is driving higher consumer disposable income, which is making the APAC market increasingly attractive for bioresorbable polymers. The expansion of healthcare infrastructure across APAC, including the rise in the number of hospitals, favorable reimbursement policies, and supportive government initiatives, further boosts the demand for these materials. Additionally, increased investment in healthcare, along with the growing need for cutting-edge surgery products and advanced medical technologies, positions APAC as a key region for the future growth of bioresorbable polymers.

From 2010 to 2018, countries in the APAC region saw an average annual real health expenditure growth rate of 6.4% per capita in GDP, as reported by the Organization for Economic Cooperation and Development (OECD). Notably, China, Turkmenistan, and Timor Leste experienced rapid growth in health expenditure per capita, which outpaced the growth of GDP per capita. Collaborations between countries like India and the U.S. to promote orthopedic research and education are also expected to boost the demand for bioresorbable polymers. For example, in March 2022, Shalby Advanced Technologies in Gujarat, India, collaborated with Gardner Orthopedics from the U.S. to establish Advanced Orthopedic Centers of Excellence in India and the U.S. These initiatives will likely drive the market for bioresorbable polymers in the APAC region, particularly in orthopedic applications.

Browse through Grand View Research's Plastics, Polymers & Resins Industry Research Reports.

• The global anhydrous hydrogen fluoride market was estimated at USD 3.33 billion in 2024 growing at a CAGR of 6.0% from 2024 to 2030.

• The global polymers & biopolymers in beauty & personal care products market size was estimated at USD 3.29 billion in 2024 and is expected to grow at a CAGR of 4.4% from 2025 to 2030.

Key Companies & Market Share Insights

To strengthen their market positions, companies in the bioresorbable polymers sector are rapidly expanding their production capabilities. With increasing governmental support focused on environmental sustainability and the growing demand for specialized orthopedic and drug delivery applications, industry players are focusing on consumer-specific product positioning strategies to gain deeper penetration in local markets.

For instance, in August 2021, Evonik Industries AG acquired JeNaCell, a German biotech company, to broaden its biomaterials portfolio within the healthcare industry. This acquisition allows Evonik’s Nutrition & Care division to expand its range of natural goods for the medical technology platform, enhancing its position in the bioresorbable polymers market. The expansion is part of Evonik’s broader strategy to transform its portfolio and develop system solutions that meet the growing needs of the healthcare sector.

Some of the major participants in the global bioresorbable polymers market include:

• Corbion NV

• Evonik Industries AG

• Poly-Med Inc.

• Foster Corp.

• Abbott

• KLS Martin Group

• 3D Biotek LLC.

• Sunstar Suisse S.A.

• DSM

• Futerro

Order a free sample PDF of the Bioresorbable Polymers Market Intelligence Study, published by Grand View Research.